Serine Racemase Expression Differentiates Aging from Alzheimer's Brain

Area of Science:

• Neuroscience and Aging Research
• Molecular Mechanisms of Neurodegeneration

Background:

• Aging is the primary risk factor for Alzheimer's disease (AD), a neurodegenerative disorder characterized by amyloid plaques, neurofibrillary tangles, and neuronal loss.
• Hippocampal neural network activity exhibits biphasic changes in AD, shifting from hyperactivation in mild cognitive impairment (AD-MCI) to hypoactivation in later stages.
• N-methyl-D-aspartate receptors (NMDA-Rs) are crucial for synaptic plasticity, and their altered activity is implicated in both aging and AD pathogenesis.

Approach:

• Reviewing existing literature on the roles of serine racemase (SR) and its product D-serine in the aging and AD brain.
• Examining the relationship between SR/D-serine levels, NMDA-R function, and cognitive decline in aging and AD.
• Investigating the differential regulation of SR in aging versus AD and its potential as a distinguishing molecular marker.

Key Points:

• Serine racemase (SR) and D-serine are decreased in the aging hippocampus, correlating with cognitive impairment.
• SR levels are elevated in the AD brain, associated with increased cognitive dysfunction, although D-serine levels show inconsistent findings.
• The activity of NMDA-Rs, modulated by D-serine, follows distinct patterns in aging and AD progression.

Conclusions:

• Serine racemase (SR) activity and D-serine levels exhibit differential regulation in aging and Alzheimer's disease (AD).
• SR may serve as a critical molecular switch differentiating the neuropathological effects of aging from those of AD.
• Further research into SR regulation could offer insights into targeted therapeutic strategies for age-related cognitive decline and AD.